The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population-Reference-Cited by-同舟云学术

The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population

Published:2021-04 Issue: Volume:51 Page:151696
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Gyan Eric,Green Andrew,Ahenkorah-Fondjo Linda,Jackson Andrew,Toss Michael S.,Akakpo Patrick Kafui,Derkyi-Kwarteng Leonard,Rahman Ganiyu A.,Owiredu William

Funder

Commonwealth Scholarship Commission

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference34 articles.

1. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome;Ginestier;Cell Stem Cell,2007

2. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis;Li;Sci Rep,2017

3. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells;Chute;Proc Natl Acad Sci U S A,2006

4. Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer;Martín;Clinical & Translational Oncology,2016

5. Prognostic impact and clinicopathological correlation of CD133 and ALDH1 expression in invasive breast cancer;Kim;J Breast Cancer,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDC45 promotes the stemness and metastasis in lung adenocarcinoma by affecting the cell cycle;Journal of Translational Medicine;2024-04-08

2. Targeting breast cancer stem cells through retinoids: A new hope for treatment;Critical Reviews in Oncology/Hematology;2023-12

3. Cancer metastasis: Molecular mechanisms and clinical perspectives;Pharmacology & Therapeutics;2023-10

4. Proteomic approaches in the study of cancers;Proteomics;2023

5. ALDH1: A potential therapeutic target for cancer stem cells in solid tumors;Frontiers in Oncology;2022-10-28